Trial Profile
Effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms secondary to benign prostate hyperplasia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2020
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 17 Mar 2020 Status changed from recruiting to discontinued.
- 18 May 2016 New trial record